Entera Bio (ENTX) Q1 2025 Earnings
ENTX·Reported May 9, 2025·Before market open
Entera Bio reported Q1 2025 revenue of $42.0K. Diluted EPS came in at $-0.06 (-20.0% YoY), beat the $-0.07 consensus by $0.01.
Revenue
$42.0K
Diluted EPS
$-0.06beat by $0.01
Consensus: $-0.07
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Entera Bio's Q1 2025 earnings report.
Entera Bio (ENTX) reported Q1 2025 earnings on May 9, 2025 before market open.
Entera Bio reported revenue of $42.0K and diluted EPS of $-0.06 for Q1 2025.
EPS beat the consensus estimate of $-0.07 by $0.01.
Compared to the same quarter a year prior, diluted EPS declined 20.0% from $-0.05.
You can read the 10-Q periodic report (0001178913-25-001674) directly on SEC EDGAR. The filing index links above go to sec.gov.